What is NDRA's relative strength rating?

NDRA ranks at the 9th percentile over 1 month, 86th percentile over 3 months, 27th percentile over 6 months, 67th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is NDRA in?

NDRA is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is NDRA in a leading sector?

Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is NDRA?

NDRA currently shows a 20-day average daily range (ADR%) of 9.1%, a 90-day beta versus the S&P 500 of 0.81. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does NDRA have a seasonal pattern?

TickerStance computes NDRA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NDRA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did NDRA last report earnings?

NDRA most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

ENDRA Life Sciences Inc. Common Stock (NDRA)

Free

Loading ticker…

Dossier · Pro

ENDRA Life Sciences Inc. Common Stock · Healthcare · Medical Equipment

$4.44▲+5.97%

Neutral · stance 50As of Thursday, June 11, 2026, posted ~17:00 ET

NDRA is on the watchlist, not confirmed.

3m RS is 86, Market Stance is mixed at 50, A/D rating B

Lenses litMarket-wide RS; lit = leaderboard

3 month86pctile

6 month27pctile

1 year67pctile

Classic66IBD pctile

LDR43leadership

0 of 5 lenses lit · avg RS pctile 58

TODAY'S READ · AS OF 2026-06-11

As of 2026-06-11, ENDRA Life Sciences Inc. Common Stock (NDRA) has a 3-month relative strength percentile of 86 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 50 (Neutral). Sector: Healthcare. Average daily range 9.1%, relative volume 0.87×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

NDRAENDRA Life Sciences Inc. Common Stock

$4.44+0.25 ▲ +5.97%

TYPE

RANGE

INDICATORS · 4SMA5.07SMA5.10S&P 500 (SPY)244.19Relative Strength1.82

DRAW

2026-06-11·O 4.23H 4.94L 4.15C 4.44+0.25 ▲·VOL 0.0M

SRC · EOD·126 SESSIONS · 1D

§ Seasonality

10y · since 2022

Best monthDec on averageavg +28.62% · 75% win · n 4

Worst monthAug on averageavg -28.08% · 25% win · n 4

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

-22.8%

+0.8%

-20.7%

40%

20%

-15.6%

+9.4%

-28.1%

-4.0%

-3.3%

-11.1%

+28.6%

Fundamentals · NDRA

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q1 · period end 2026-03-31

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

Insufficient history: EPS 4Q, revenue 8Q (6Q minimum)

View fundamental leadership map

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

—

−$9.54—

24 Q3

−$1.86—

25 Q1

−$2.10—

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

BAccum

ETF OWNERS

ETFs holding NDRA

NDRA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $13K notional.

ETFs holding: 1
Total value: $13K
Top 3 concentration: 100.0%
Max weight: VXF · 0.00%

Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding NDRA ranked by value
ETF	Weight	Value
VXFVanguard Extended Market ETF	0.00%	$13K

FAQ

Frequently asked questions

What is NDRA's relative strength rating?: NDRA ranks at the 9th percentile over 1 month, 86th percentile over 3 months, 27th percentile over 6 months, 67th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is NDRA in?: NDRA is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is NDRA in a leading sector?: Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is NDRA?: NDRA currently shows a 20-day average daily range (ADR%) of 9.1%, a 90-day beta versus the S&P 500 of 0.81. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does NDRA have a seasonal pattern?: TickerStance computes NDRA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NDRA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did NDRA last report earnings?: NDRA most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

NDRA is on the watchlist, not confirmed.

§ Seasonality

Does the business back the chart?

Is earnings accelerating?

Receipts behind the read

Is it leading?

Who's accumulating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Company snapshot

ETFs holding NDRA

Frequently asked questions

§ Seasonality

ENDRA Life Sciences Inc. Common Stock (NDRA) — Stance & relative strength

NDRA is on the watchlist, not confirmed.

Does the business back the chart?

Is earnings accelerating?

Receipts behind the read

Is it leading?

Who's accumulating?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Company snapshot

ETFs holding NDRA

Frequently asked questions